Roy Fleischmann

基本信息

浏览量：159

职业迁徙

个人简介

Dr Fleischmann has been involved in the development of virtually all medications approved for rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus and osteoarthritis in the USA, and has presented globally on their development. In addition, he has published approximately 300 peer-reviewed manuscripts and presented approximately 500 abstracts at major rheumatology meetings. Dr Fleischmann is editor-in-chief of Rheumatology and Therapy, sits on the editorial boards of Annals of the Rheumatic Diseases, RMD Open and The Journal of Rheumatology, and was a past international editor for Rheumatology (Oxford). In addition, he has acted as peer reviewer for multiple journals including Arthritis & Rheumatology, Arthritis Care & Research, Annals of Internal Medicine, New England Journal of Medicine, The Lancet, The Lancet Rheumatology and Journal of the American Medical Association.

研究兴趣

论文共 713 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Have We Found a True Disease-Modifying Osteoarthritis Drug (DMOAD) or is There Still Much Work to Be Done

Roy Fleischmann

Rheumatology (Oxford, England)no. 5 (2025): 2345-2346

引用0浏览0WOS引用

Safety of Janus Kinase Inhibitors in Immune-Mediated Inflammatory Diseases - a Systematic Literature Review Informing the 2024 Update of an International Expert Consensus Statement

Victoria Konzett,Josef S Smolen,Peter Nash,Kevin Winthrop,Daniel Aletaha,Thomas Dörner,Roy Fleischmann,Yoshiya Tanaka,Jette Primdahl,Xenofon Baraliakos,Iain B McInnes,Michael Trauner,Naveed Sattar,Maarten de Wit,Jan W Schoones,Andreas Kerschbaumer

Annals of the rheumatic diseasesno. 5 (2025): 697-715

引用0浏览0WOS引用

Expert Consensus Statement on the Treatment of Immune-Mediated Inflammatory Diseases with Janus Kinase Inhibitors: 2024 Update

Annals of the rheumatic diseasesno. 5 (2025): 664-679

引用0浏览0WOS引用

Benefit-risk Analysis of Upadacitinib Versus Adalimumab in Patients with Rheumatoid Arthritis and Higher or Lower Risk of Cardiovascular Disease

Gerd R Burmester,Eduardo Mysler,Peter Taylor, Stephen Hall, Bettina Wick-Urban,Andrew Garrison, Tianming Gao, Irina Fish,Sander Strengholt,Roy Fleischmann

RMD openno. 2 (2025)

引用0浏览0WOS引用

Association Between Abatacept Exposure Levels and Infection Occurrence in Patients with Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study

Paul Emery,Roy Fleischmann,Robert Wong,Karissa Lozenski,Yoshiya Tanaka, Vivian Bykerk,Clifton O Bingham,Thomas W J Huizinga,Gustavo Citera,Vidya Perera,Bindu Murthy, Kelly Fellows Maxwell,Julie Passarell, William D Hedrich,Daphne Williams

The Journal of rheumatologyno. 5 (2025): 426-435

引用0浏览0WOS引用

Acknowledgement of Referees

Giovanni Adami,Graciela Alarcon, Daniel Albert, Kelli Allen,Martin Aringer,Elizabeth V. Arkema,Hossam M. Ashour, Fabiola Atzeni, Gizem Ayan, Alan Baer,Joshua Baker, Claire Barber, Wilson Bautista-Molano,Sara Beça, Brock Beamer,Sytske Anne Bergstra, Bonnie Bermas, Emre Bilgin,Maarten Boers, Marcy Bolster, Julian Bosco,Jocelyn L. Bowden,Frank Buttgereit,Leonard Calabrese, Corrado Campochiaro,Laura Cappelli, Loreto Carmona, Jozelio Carvalho, Santos Castañeda, Chao, Soumya Chatterjee, L. Cherry, Robin Christensen,Laura C. Coates,Stanley B. Cohen, Jamie E. Collins,Divi Cornec,Maria Antonietta D'Agostino, Thomas Daikeler, Salvatore D'Angelo, Hubert de Boysson, Pamela de Jong, Maarten de Wit,Paul Dellaripa, Patrick Dessein, Torsten Diekhoff,Michaël Doumen, Felix Eckstein,Muriel Elhai, Jessica L. Fairley, David Felson, Ivan Ferraz Amaro, Elizabeth Ferucci,David Fiorentino, John FitzGerald,Roy Fleischmann,James Galloway,Rodrigo Garcia Salinas,Valeria Giorgi,Yvonne Golightly, Takahisa Gono, Miguel Angel Gonzalez-Gay, Andreas Goules,Ellen Gravallese, Melissa Griffith,Sergei Grosman, Latika Gupta, Vedat Hamuryudan, Claudia Hana,Judith Haschka,Gillian Hawker, Juan Pablo Hervas-Perez, Alojzija Hocevar,Michele Iudici,Priyanka Iyer, Mahajne Jasmin, Marc Judson,Andreas Kerschbaumer, David Kiefer, Uta Kiltz, Shaye Kivity,Joel M. Kremer,Féline PB Kroon, Shiloah Kviatkovsky, Brian S. Lee,David Liew,Sian Yik Lim, Geoffrey Littlejohn, Clementina Lopez Medina, Walter Maksymowych, Lyn March, Hubert Marotte, Oriol Martinez Navarro, Clio Mavragani,Iain McInnes, Zsuzsanna McMahan,Alexa Meara, Christopher Mecoli,Tony Merriman,Jamal Mikdashi,Ted Mikuls, Durga Prasanna Misra, Braxton D. Mitchell, Terry Moore,Haralampos Moutsopoulos, Esperanza Naredo, Peter Nash, Michael Nurmohamed,Chester Oddis,Samar Ojaimi,Melissa Oliver,Seza Ozen, Salih Ozgocmen,Andriko Palmowski, Tristan Pascart,Apostolos Perelas, Kevin Pile, Theodore Pincus,Denis Poddubnyy, Sofia Ramiro, Amit Reddy, Anne Regierer, Dario Roccatello,Tasmin Rookes, Ann Rosenthal,Tamar Rubinstein, Martin Rudwaleit,Javier Rueda-Gotor, Violeta Rus, Lesley Ann Saketkoo, Maxime Samson,Peter Schur,Alexandre Sepriano,Soraya Shadmanfar,Anna Shmagel, Wilmer L. Sibbitt, Alexandre W. Silva de Souza, Catherine Sims, Namrata Singh, Christopher Sjöwall,Vanessa Smith, Jason Jungsik Song, Enrique R. Soriano,Jeffrey Sparks,Paul Studenic, Takahiko Sugihara,Samy Suissa,Zoltán Szekanecz, Koray Tascilar,Peter Taylor, Robert Terkeltaub,Eleni Tiniakou, Nevins Todd,Guilherme Torres Vilarino,Erin Treemarcki, Hideaki Tsuji,Carl Turesson, Marinka Twilt, Dimitrios Vassilopoulos, Tamara Vojinovic,Elizabeth Volkmann,Debby Vosse, Linda Wagner-Weiner, Zachary Scott Wallace,Daniel Wallace, Guo-chun Wang, Jie Wei, Michael H. Weisman,Rene Westhovens,Kevin Winthrop,Katherine D. Wysham, Jing Xue, Chengde Yang, Michelle Yau,Yusuf Yazici,Hasan Yazici, Isaac Cheuk Wan YIM, James Young, Wen Zhang

Seminars in Arthritis and Rheumatism (2024)

引用0浏览0引用

Relationship Between Disease Activity and Adverse Events in Rheumatoid Arthritis: an Integrated Post Hoc Analysis of Upadacitinib Phase 3 Trials